Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 20, 2021
High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...
Blog Post
December 20, 2021
CGD co-hosted an online event in November with the U4 Anti-Corruption Resource Centre to discuss the progress and challenges in pursuit of a transparent and equitable roll out of COVID-19 vaccine. Following on earlier calls for transparency, this event built on new research from U4 and pointed ...
Blog Post
December 13, 2021
In the language of economists, opportunity cost refers to the return or other forms of benefit that we could have received, but gave up, to take another course of action. In mathematical terms, it is the difference between the utility of what we have chosen and that from the foregone choice. Or, in ...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Dec
15
2021
9:00—10:15 AM Eastern Time
December 06, 2021
There have been several explorations and a few impactful uses of Machine Learning (ML) and advanced analytics during the COVID-19 pandemic. A lot of the discussion around the use of ML has centered around their use for case projections, accelerating the development of vaccines and treatments, and ne...
Blog Post
December 01, 2021
We worked with the Joint Learning Network (JLN) Efficiency Collaborative to gain insights from Collaborative members who represent technical staff and decision-makers working at the heart of health benefit packages development and revisions in eleven low-and middle-income countries in Africa and Asi...
Nov
30
2021
9:00—10:15 AM Eastern Time (US and Canada)
November 17, 2021
Ineffective and inefficient registration processes impede access to lifesaving, quality-assured essential medicines. As a result of inadequate legal provisions, limited capacity within National Regulatory Authorities, and long and unpredictable registration processes as well as low profit margins an...